Self-Monitoring Blood Glucose (SMBG) device market is providing big business opportunities for device manufactures in the Europe. It is projected that Europe Blood Glucose Device market will climb to nearly US$ 8 Billion landmark by the end of 2024. Driving factors which help to reach this market are increasing diabetic population in the European countries, Governments and NGOs efforts to increase awareness, increasing per capita healthcare expenditure and availability of reimbursements in most of the European countries.
Diabetes is a condition in which blood sugar level is abnormal; either it is high or low of given standard. It is two types - Type 1 and Type 2. In Type 1 diabetes, body does not make insulin whereas in Type 2, body makes irregular insulin sometimes high and sometimes low which is not good for human body. In European region, diabetic mellitus population is steadily rising in United Kingdom, Spain, Netherlands and Norway countries.
Europe Blood Glucose Device Market, Forecast SMBG Components (Test Strips, Lancet, Meter), Diabetes Population (Type 1 & 2) published by Renub Research studies the European Countries Blood Glucose Device Segments Market: Blood Glucose Test Strips Market, Blood Glucose Lancet Market and Blood Glucose Meter Market. Annual forecast are provided for the period of 2018 through 2024. A Seven year historic analysis is also provided for these markets.
By Diabetes - Population Segmentation All the European countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland and Russia) in the report have been covered with the details of Total Diabetic Population, Type 1 Diabetic Population and Type 2 Diabetic Population. A Seven year historic analysis and annual forecast is also included in this study.
By SMBG – Segmentation This report provides the details of European country specific SMBG users and market, test strips market, lancet market and glucose meter market.
By Test Strips – Country Segmentation The report has also been further segmented on the test strips basis that includes blood glucose test strips historical and forecasted market size in United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland and Russia. United Kingdom and Russia represents a significant market.
By Lancet – Country Segmentation Lancet is playing the significant role in the Europe SMBG market. Under this segment blood glucose lancet market is defined for the following countries: United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland and Russia.
By Blood Glucose Meter – Country Segmentation This report studies the Blood glucose meter market size in various European countries such as United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland and Russia. It is 2nd most important segment in the Europe SMBG market.
SMBG Segments covers in this study
All the 4 countries in the report have been studied from 7 viewpoints. • Europe Countries Diabetes Population • Europe Countries Type 1 and Type 2 Diabetes • Europe Countries Self-Monitoring Blood Glucose (SMBG) Devices Users • Europe Countries Self-Monitoring Blood Glucose Devices (SMBG) Market • Europe Countries Blood Glucose Test Strips Market • Europe Countries Blood Glucose Lancet Market • Europe Countries Blood Glucose Meter Market
Countries cover in this study • United Kingdom • Germany • Spain • Italy • Netherlands • Norway • Sweden • Switzerland • Russia
This Report is useful for those who want to know • European region as well as country specific SMBG device market, SMBG device segments (Blood Glucose Meter, Test Strips and Lancet) market • Countries Diabetes Scenario (Total Number of Diabetic Mellitus Population, Type 1 & Type 2 Diabetic Population) • Countries Reimbursement Policy on Diabetic Care and SMBG Devices
Our reports have been used by over 10K customers, including:
The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and...
The global remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden...
The Global Remote Patient Monitoring market is expected to reach US$ 1,544.94 Mn in 2027 from US$ 712.21 Mn in 2018. The market is estimated to grow with a CAGR of 9.3% from 2019-2027. The growth of the Remote Patient Monitoring market is primarily attributed to the factors such as increasing prevalence of chronic diseases, rising geriatric...
Chronic Disease Prevalence
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.